Teva, others settle Ohio opioid cases; Q3 earnings; First in Human

October 30, 2019
Annalee Armstrong, Ephraim Bie, and Ricky Zipp, S&P Global
400699021.jpg
Summit county executive Ilene Shapiro speaks to media at the U.S. Federal courthouse in Cleveland on Oct. 21, where a high profile trial examining pharmaceutical companies' role in the opioid epidemic was expected to take place. Source: AP Photo

Four companies cited in a lawsuit from counties in Ohio seeking to place blame for the ongoing opioid epidemic have settled the so-called bellwether case for a total of $265 million, attorney Hunter Shkolnik, who represents the counties, told S&P Global Market Intelligence.

Drug manufacturer Teva Pharmaceutical Industries Ltd. will pay $20 million up front, plus provide $25 million worth of the opioid addiction treatment Suboxone. The company is also nearing a comprehensive deal worth about $23 billion that would settle all cases being levied against it.

Read More

Tags for this resource

Explore all tags

Visit The Emerald Jenny Foundation to find treatment in Ohio.

The Emerald Jenny Foundation
Close
Search